Burnie Academy
Pemvidutide: a GLP-1 + glucagon dual drug in trials

Pemvidutide: a GLP-1 + glucagon dual drug in trials

Pemvidutide is an experimental weight-loss shot that targets two body signals at once. It is still in trials, not approved, and not sold anywhere, including India.

13 Jul 2026 · Burnie Academy
pemvidutide glp-1 glucagon clinical-trials

You may have heard friends talk about a 'new weight-loss shot.' One name popping up in news is pemvidutide. It sounds exciting because it does two things at once. But here is the honest truth first: pemvidutide is still being tested. No doctor can prescribe it yet. It is not in any shop, not online, and not in India. This short read tells you what it is, what the trials found, and why you should wait.

CONTINUE READING FOR FREE

Unlock the complete article

Register with just your mobile number and OTP. No password and no payment.

Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.

By continuing, you agree to Burnie's Terms and Privacy Policy.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Sign in with the same mobile number you use for Academy. Android public availability is being expanded.